Homozygotes have normal wing veins.
53.7% of females expressing EloAG4930 under the control of Scer\GAL4sd.PU have ectopic wing veins. Wing margin defects are also seen.
85.5% of females expressing EloAG4930 under the control of Scer\GAL4Bx-MS1096 have ectopic wing veins.
Clones expressing EloAG4930 under the control of Scer\GAL4Act5C.PP results in wing margin and wing vein defects.
The penetrance of the ectopic wing vein phenotype seen in corto07128b/+ females (over 90% penetrance) is reduced if they are also heterozygous for EloAG4930 (38.3% penetrance).
The ectopic wing vein phenotype seen in cortol1/+ females is suppressed if they are also heterozygous for EloAG4930.
The penetrance of the ectopic wing vein phenotype seen in mor1/+ females (22.5% penetrance) is reduced if they are also heterozygous for EloAG4930 (5.5% penetrance).
The penetrance of the ectopic wing vein phenotype seen in kis1/+ females (81.5% penetrance) is reduced if they are also heterozygous for EloAG4930 (48.8% penetrance).
The penetrance of the ectopic wing vein phenotype seen in trxE2/+ females (53.9% penetrance) is reduced if they are also heterozygous for EloAG4930 (10.4% penetrance).